(Q34816036)

4 August 2017

title

Modeling the benefits of pamidronate in children with osteogenesis imperfecta (English)

1 reference

4 August 2017

main subject

osteogenesis imperfecta

0 references

author name string

Robert Lindsay

series ordinal

1

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Journal of Clinical Investigation

4 August 2017

published in

1 reference

4 August 2017

volume

110

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

1239-1241

1 reference

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151622

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151622

Sexual dimorphism in vertebral fragility is more the result of gender differences in age-related bone gain than bone loss

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151622

Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151622

Type V osteogenesis imperfecta: a new form of brittle bone disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151622

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151622

Genetic heterogeneity in osteogenesis imperfecta

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151622

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151622

Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151622

Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151622

26 October 2018

Identifiers

DOI

10.1172/JCI0217051

1 reference

4 August 2017

1 reference

4 August 2017

1 reference